1. Home
  2. SANG vs HUMA Comparison

SANG vs HUMA Comparison

Compare SANG & HUMA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Sangoma Technologies Corporation

SANG

Sangoma Technologies Corporation

HOLD

Current Price

$4.62

Market Cap

163.0M

Sector

Technology

ML Signal

HOLD

Logo Humacyte Inc.

HUMA

Humacyte Inc.

N/A

Current Price

$1.08

Market Cap

182.6M

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
SANG
HUMA
Founded
1984
2004
Country
Canada
United States
Employees
N/A
N/A
Industry
Computer Software: Programming Data Processing
Biotechnology: Pharmaceutical Preparations
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
163.0M
182.6M
IPO Year
2018
N/A

Fundamental Metrics

Financial Performance
Metric
SANG
HUMA
Price
$4.62
$1.08
Analyst Decision
Strong Buy
Analyst Count
0
8
Target Price
N/A
$10.00
AVG Volume (30 Days)
5.5K
5.4M
Earning Date
01-01-0001
01-01-0001
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
$5.07
$731.05
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$4.08
$0.88
52 Week High
$6.46
$3.94

Technical Indicators

Market Signals
Indicator
SANG
HUMA
Relative Strength Index (RSI) 43.95 52.42
Support Level $4.40 $0.92
Resistance Level $4.98 $1.25
Average True Range (ATR) 0.12 0.10
MACD -0.01 0.02
Stochastic Oscillator 40.00 55.73

Price Performance

Historical Comparison
SANG
HUMA

About SANG Sangoma Technologies Corporation

Sangoma Technologies Corp is a provider of hardware and software components that enable or enhance Internet Protocol Communications Systems for both telecom and datacom applications. It is engaged in the development, manufacturing, distribution, and support of voice and data connectivity components for software-based communication applications. Its product includes data and telecom boards for media and signal processing, as well as gateway appliances and software. The Company sells into two geographic centers: USA and Other countries. Key revenue is generated from USA.

About HUMA Humacyte Inc.

Humacyte Inc is developing a disruptive biotechnology platform to deliver universally implantable bioengineered human tissues and organs designed to improve the lives of patients and transform the practice of medicine. It develops and manufactures acellular tissues to treat a wide range of diseases, injuries, and chronic conditions. Company's pipeline includes Vascular Trauma, PAD, Dailysis, Acellular Tissue Engineered Vessels, Organ Systems, Advanced Tissue Constructs.

Share on Social Networks: